Cu67 Production via Zn68 Photonuclear Transmutation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing Copper-67 (Cu67) radioisotope, such as nuclear reactors and proton accelerators, face challenges in achieving high purity and specific activity due to contamination, limited production rates, and costly waste handling, which hinder its application in medical therapy.

Innovation Solution

A photonuclear method involving irradiation of metallic zinc-68 with a high-energy gamma ray beam to convert Zn68 to Cu67, followed by isolation and purification through sublimation and chemical means, utilizing a target holder assembly and titanium apparatus for efficient production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If nuclear reactors are used to produce Cu67, then production can be achieved, but harmful unwanted isotopes are generated that are difficult to remove and require costly waste handling

Engineering Contradiction:
ImproveCu67 production quantityVSAvoidunwanted isotopes and radioactive waste
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent extracts only the desired Cu67 isotope from the target material through selective photonuclear reactions using high-energy gamma rays (e.g., from an electron linac). This method produces Cu67 without generating the complex mixture of unwanted isotopes that occur in reactor production, thereby eliminating the need for complex separation and waste handling processes.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses a zinc-68 enriched target as an intermediary material that undergoes photonuclear transformation to produce Cu67. This intermediary approach allows selective production of the desired isotope without the contamination issues inherent in direct reactor irradiation of copper targets.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If proton accelerators are used to produce Cu67, then Cu67 can be produced, but production rates are limited and the process requires vacuum irradiation followed by atmospheric opening for target recovery

Engineering Contradiction:
ImproveCu67 production quantityVSAvoidproduction rate and process efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent replaces the mechanical vacuum-seal-open cycle required in proton accelerator production with a photonuclear method that can be performed continuously. The high-energy gamma rays from an electron linear accelerator induce nuclear reactions in the zinc target without requiring vacuum conditions, allowing the target to remain in place and enabling continuous production and direct recovery of Cu67.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Quantity of substance

If reactor production methods are used, then Cu67 can be produced, but sophisticated mechanical retrieval systems and extensive waste handling are required

Engineering Contradiction:
ImproveCu67 production quantityVSAvoidmechanical rabbit system and waste handling infrastructure
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent employs a disposable or easily replaceable zinc target that can be irradiated and then processed chemically to extract Cu67. This eliminates the need for sophisticated mechanical retrieval systems required in reactor production, where targets must be inserted into and retrieved from the reactor core through complex mechanisms.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Manufacturing precision

If conventional production methods are used, then Cu67 can be produced, but achieving high purity and specific activity suitable for medical applications is difficult

Engineering Contradiction:
Improvepurity and specific activity of Cu67VSAvoidCu67 production quantity
Core Design Contradiction:
Manufacturing precisionVSQuantity of substance

Solution Approach 1:

The patent changes the fundamental production parameters by using photonuclear reactions with high-energy gamma rays (typically 10-100 MeV) on zinc-68 enriched targets. This produces Cu67 with high specific activity because the reaction selectively transforms Zn68 to Cu67 without producing significant amounts of stable copper isotopes or other unwanted copper isotopes, thereby achieving both high purity and high specific activity in a single production step.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS8526561B2Methods for making and processing metal targets for producing Cu-67 radioisotope for medical applications
Publication Date: 2013.09.03 UCHICAGO ARGONNE LLC
  • US8526561B2 patent drawing
  • US8526561B2 patent drawing
  • US8526561B2 patent drawing

AI summary

The present invention provides a method for producing Cu67 radioisotope suitable for use in medical applications. The method comprises irradiating a metallic zinc-68 (Zn68) target with a high energy gamma ray beam. After irradiation, the Cu67 is isolated from the Zn68 by any suitable method (e.g., chemical and/or physical separation). In a preferred embodiment, the Cu67 is isolated by sublimation of the zinc (e.g., at about 500-700° C. under reduced pressure) to afford a copper residue containing Cu67. The Cu67 can be further purified by chemical means (i.e., dissolution in acid, followed by ion exchange).